Free Estradiol and Breast Cancer Risk in Postmenopausal Women: Comparison of Measured and Calculated Values

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 12, 2003, Pages 1457-1461

  Key, T J ^a   Appleby, P N ^a   Reeves, G K ^a   Roddam, A W ^a   Dorgan, J F ^b   Longcope, C ^c   Stanczyk, F Z ^d   Stephenson, H E ^e   Falk, R T ^f   Miller, R ^e   Schatzkin, A ^f   Allen, D S ^g   Fentiman, I S ^g   Wang, D Y ^g   Dowsett, M ^h   Thomas, H V ⁱ   Hankinson, S E ^j,k   Toniolo, P ^l   Akhmedkhanov, A ^l   Koenig, K ^l   Shore, R E ^l   Zeleniuch Jacquotte, A ^l   Berrino, F ^m   Muti, P ⁿ   Micheli, A ^m   Krogh, V ^m   Sieri, S ^m   Pala, V ^m   Venturelli, E ^m   Secreto, G ^m   Barrett Connor, E ^o   Laughlin, G A ^o   Kabuto, M ^p   Akiba, S ^q   Stevens, R G ^r   Neriishi, K ^s   Land, C E ^f   Cauley, J A ^t   Kuller, L H ^t   Cummings, S R ^u   Helzlsouer, K J ^v   Alberg, A J ^v   Bush, T L ^v   Comstock, G W ^v   Gordon, G B ^w   Miller, S R ^v   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b FOX CHASE CANCER CENTER   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF MISSOURI   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g Cancer Research   (United Kingdom)

^h Royal Marsden Hospital   (United Kingdom)

ⁱ CARDIFF UNIVERSITY   (United Kingdom)

^j HARVARD MEDICAL SCHOOL   (United States)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^l NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m NATIONAL CANCER INSTITUTE   (Italy)

ⁿ UNIVERSITY AT BUFFALO   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^q KAGOSHIMA UNIVERSITY   (Japan)

^r UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^s Radiation Effects Research Foundation   (United States)

^t UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^u UNIVERSITY OF CALIFORNIA   (United States)

^v JOHNS HOPKINS UNIVERSITY   (United States)

^w JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ESTRADIOL; SEX HORMONE; SEX HORMONE BINDING GLOBULIN;

ARTICLE; BREAST CANCER; CALCULATION; CANCER INCIDENCE; CANCER RISK; COMPARATIVE STUDY; CONTROLLED STUDY; COST CONTROL; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE PROTEIN COMPLEX; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; MEASUREMENT; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SERUM;

EID: 0347993723     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. The Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl. Cancer Inst. (Bethesda), 94: 606-616, 2002.
2. Sodergard, R., Backstrom, T., Shanbhag, V., and Carstensen, H. Calculation of free and bound fractions of testosterone and estradiol-17 β to human plasma proteins at body temperature. J. Steroid Biochem., 16: 801-810, 1982.
3. Dunn, J. F., Nisula, B. C., and Rodbard, D. Transport of steroid-hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human-plasma. J. Clin. Endocrinol. Metab., 53: 58-68, 1981.
4. Pardridge, W. M. Transport of protein bound hormone into tissues in vivo. Endocr. Rev., 2: 3-123, 1981.
5. Pearlman, W. H., and Crepy, O. Steroid-protein interaction with particular reference to testosterone binding by human serum. J. Biol. Chem., 242: 182-189, 1976.
6. Belgorosky, A., Escobar, M. E., and Rivarola, M. A. Validity of the calculation of non-sex hormone-binding globulin-bound estradiol from total testosterone, total estradiol and sex hormone-binding globulin concentrations in human serum. J. Steroid. Biochem., 28: 429-432, 1987.
7. Vermeulen, A., Verdonck, L., and Kaufman, J. M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab., 84: 3666-3672, 1999.
8. Rinaldi, S., Geay, A., Dechaud, H., Biessy, C., Zeleniuch-Jacquotte, A., Akhmedkhanov, A., Shore, R. E., Riboli, E., Toniolo, P. G., and Kaaks, R. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol. Biomark. Prev., 11: 1065-1071, 2002.
9. Dorgan, J. F., Longcope, C., Stephenson, H. E., Falk, R. T., Miller, R., Franz, C., Kahle, L., Campbell, W. S., Tangrea, J. A., and Schatzkin, A. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol. Biomark. Prev., 5: 533-539, 1996.
10. Dorgan, J. F., Stanczyk, F. Z., Longcope, C., Stephenson, H. E., Chang, L., Miller, R., Franz, C., Falk, R. T., and Kahle, L. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 β, 17 β-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiol. Biomark. Prev., 6: 177-181, 1997.
11. Thomas, H. V., Key, T. J., Allen, D. S., Moore, J. W., Dowsett, M., Fentiman, I. S., and Wang, D. Y. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guemsey. Br. J. Cancer, 76: 401-405, 1997.
12. Hankinson, S. E., Willett, W. C., Manson, J. E., Colditz, G. A., Hunter, D. J., Spiegelman, D., Barbieri, R. L., and Speizer, F. E. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst. (Bethesda), 90: 1292-1299, 1998.
13. Berrino, F., Muti, P., Micheli, A., Bolelli, G., Krogh, V., Sciajno, R., Pisani, P., Panico, S., and Secreto, G. Serum sex hormone levels after menopause and subsequent breast cancer. J. Natl. Cancer Inst. (Bethesda), 88: 291-296, 1996.
14. Barrett-Connor, E., Friedlander, N. J., and Khaw, K. T. Dehydroepiandrosterone sulfate and breast-cancer risk. Cancer Res., 50: 6571-6574, 1990.
15. Garland, C. F., Friedlander, N. J., Barrett-Connor, E., and Khaw, K. T. Sex-hormones and postmenopausal breast-cancer: a prospective study in an adult community. Am. J. Epidemiol., 135: 1220-1230, 1992.
16. Kabuto, M., Akiba, S., Stevens, R. G., Neriishi, K., and Land, C. E. A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol. Biomark. Prev., 9: 575-579, 2000.
17. Cauley, J. A., Lucas, F. L., Kuller, L. H., Stone, K., Browner, W., and Cummings, S. R. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Ann. Intern. Med., 130: 270-277, 1999.
18. Gordon, G. B., Bush, T. L., Helzlsouer, K. J., Miller, S. R., and Comstock, G. W. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast-cancer. Cancer Res., 50: 3859-3862, 1990.
19. Helzlsouer, K. J., Alberg, A. J., Bush, T. L., Longcope, C., Gordon, G. B., and Comstock, G. W. A prospective study of endogenous hormones and breast cancer. Cancer Detect. Prev., 18: 79-85, 1994.
20. Bland. J. M., and Altman, D. G. Measuring agreement in method comparison studies. Stat. Methods Med. Res., 8: 135-160, 1999.
21. Ihaka, R., and Gentleman, R. R. A language for data analysis and graphics. J. Comput. Graph. Stat., 5: 299-314, 1996.
22. Fisher, R. A., and Burke, C. W. Simultaneous measurement of unbound testosterone and estradiol fractions in undiluted plasma at 37C by steady-state gel filtration. Steroids, 24: 809-824, 1974.
23. Moll, G. W., and Rosenfield, R. L. Testosterone binding and free plasma androgen concentrations under physiological conditions: characterisation by flow dialysis. J. Clin. Endocrinol. Metab., 49: 730-736, 1979.
24. Hammond, G. L., Nisker, J. A., Jones, L. A., and Siiteri, P. K. Estimation of the percentage of free steroid in undiluted serum by centrifugal ultrafiltration-dialysis. J. Biol. Chem., 255: 5023-5026. 1980.
25. Stumpf, P. G., Nakamura, R. M., and Mishell, D. R. Changes in physiologically free circulating estradiol and testosterone during exposure to levonorgestrel. J. Clin. Endocrinol. Metab., 52: 138-143, 1981.
26. Bonfrer, J. M. G., Bruning, P. F., and Nooijen, W. J. A simple method for the measurement of the steroid fraction bound to sex hormone binding globulin in serum. J. Steroid Biochem., 33: 227-231, 1989.
27. Longcope, C., Hui, S. L., and Johnston, C. C. Free E2, free testosterone and sex hormone binding globulin in peri-menopausal women. J. Clin. Endocrinol. Metab., 64: 513-518, 1987.
28. Moll, G. W., Rosenfield, R. L., and Helke, J. H. Estradiol-testosterone binding interactions and free plasma estradiol under physiological conditions. J. Clin. Endocrinol. Metab., 52: 868-874, 1981.
29. Vermeulen, A., Stoica, T., and Verdonck, L. The apparent free testosterone concentration, an index of androgenicity. J. Clin. Endocrinol. Metab., 33: 759-767, 1971.
30. Vermeulen, A., Verdonck, L., Van der Straaeten, M., and Orie, N. Capacity of the testosterone-binding globulin in human plasma and influence of specific binding of testosterone on its metabolic clearance rate. J. Clin. Endocrinol. Metab., 29: 1470-1480, 1969.